Evidence map›Paper›PMID 42653175›Full record

ArticleInternational journal of molecular sciences2026

A Case of Acute Myeloid Leukemia, Myelodysplasia-Related (AML-MR) with Immunophenotypic Features Suggestive of B/Myeloid Mixed-Phenotype Acute Leukemia (MPAL), Harboring Multiple

Jakub Łączak, Marta Szarawarska, Dominika Dudycz, Karolina Bieńko, Jarosław Grzyb, Tomasz Skoczylas, Beata Blajer-Olszewska, Agnieszka Kopacz, Mirosław Markiewicz

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jakub ŁączakDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Marta SzarawarskaDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Dominika DudyczDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Karolina BieńkoDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Jarosław GrzybDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.ORCID 0009-0005-0432-7662
Tomasz SkoczylasDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Beata Blajer-OlszewskaDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Agnieszka KopaczDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.
Mirosław MarkiewiczDepartment of Hematology, F. Chopin University Clinical Hospital, 35-055 Rzeszów, Poland.ORCID 0000-0002-8550-8908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amplification of

Indexed as

Gene AmplificationHistone-Lysine N-MethyltransferaseLeukemia, Biphenotypic, AcuteLeukemia, Myeloid, AcuteMyeloid-Lymphoid Leukemia ProteinHumansImmunophenotypingMaleMiddle AgedHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia Proteingene amplificationKMT2Amixed phenotype acute leukemia

Identifiers

PMID42653175
PMCPMC13513549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.